Bone Marrow TransplantationTissue DonorsHistocompatibility TestingTransplantation, HomologousGraft vs Host DiseaseBone MarrowHistocompatibilityBone Marrow CellsGraft SurvivalTransplantation ChimeraWhole-Body IrradiationTransplantation ConditioningAnemia, AplasticTransplantation, AutologousLeukemiaHematopoietic Stem Cell TransplantationSurvival AnalysisGraft RejectionKidney TransplantationHematopoietic Stem CellsBone and BonesHLA AntigensLeukocyte TransfusionTransplantation, IsogeneicRadiation ChimeraImmunosuppressive AgentsImmunosuppressionTransplantation ToleranceGraft Enhancement, ImmunologicLiver TransplantationRecurrenceBone Marrow PurgingMice, Inbred C57BLTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsBusulfanHeart TransplantationBone Marrow DiseasesTransplantation ImmunologySkin TransplantationTissue and Organ ProcurementLiving DonorsLymphocyte DepletionAcute DiseaseGraft vs Host ReactionT-LymphocytesChimerismCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationHematologic NeoplasmsActuarial AnalysisHematopoiesisBone Marrow NeoplasmsBlood DonorsCombined Modality TherapyLeukemia, Myeloid, AcuteRetrospective StudiesDisease-Free SurvivalLymphocyte Culture Test, MixedRemission InductionChimeraLung TransplantationHepatic Veno-Occlusive DiseaseMice, Inbred BALB CLeukemia, MyeloidColony-Forming Units AssayStem Cell TransplantationBone RemodelingCyclosporineLymphoma, Non-HodgkinCord Blood Stem Cell TransplantationLymphocyte TransfusionMyelodysplastic SyndromesSurvival RateSevere Combined ImmunodeficiencyHematologic DiseasesCell DifferentiationCytomegalovirus InfectionsFlow CytometryMice, Inbred C3HFollow-Up StudiesTransplantationImmune ToleranceSpleenPancytopeniaAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyBone DensityTransplantsLeukocyte CountGranulocyte Colony-Stimulating FactorCells, CulturedCarmustineGraft vs Tumor EffectOrgan TransplantationCytarabineMultiple MyelomaGraft vs Leukemia Effect